AZD-1981
- Generic Name
- AZD-1981
- Drug Type
- Small Molecule
- Chemical Formula
- C19H17ClN2O3S
- CAS Number
- 802904-66-1
- Unique Ingredient Identifier
- 2AD53WQ2CX
- Background
AZD1981 has been used in trials studying the treatment and basic science of Asthma, Postmenopausal, Pharmakokinetic, Asthma Patients, and Drug Interaction, among others.
Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 38
- Registration Number
- NCT02031679
- Locations
- πΊπΈ
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States
A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of Pravastatin
- First Posted Date
- 2010-12-06
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT01254461
- Locations
- πΈπͺ
Research Site, Uppsala, Sweden
A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2011-02-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 28
- Registration Number
- NCT01199341
- Locations
- πΈπͺ
Research Site, Uppsala, Sweden
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
- First Posted Date
- 2010-09-09
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1144
- Registration Number
- NCT01197794
- Locations
- πΊπ¦
Research Site, Zaporozhye, Ukraine
A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives
Phase 1
Completed
- Conditions
- Oral Contraceptives
- Interventions
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2010-11-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 28
- Registration Number
- NCT01110525
- Locations
- πΈπͺ
Research Site, Uppsala, Sweden
Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers
- First Posted Date
- 2010-01-28
- Last Posted Date
- 2010-11-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 4
- Registration Number
- NCT01058447
AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 14
- Registration Number
- NCT00918398
- Locations
- πΈπͺ
Research Site, Uppsala, Sweden
AZD1981 Midazolam CYP4503A Induction Study
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2009-04-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 28
- Registration Number
- NCT00859352
- Locations
- πΈπͺ
Research Site, Uppsala, Sweden
14729-D9831C00002- 1 Month Biopsy Study
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-10-06
- Last Posted Date
- 2014-02-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 52
- Registration Number
- NCT00766415
- Locations
- π¬π§
Research Site, Newcastle upon Tyne, United Kingdom
One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2014-02-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 368
- Registration Number
- NCT00758589
- Locations
- π΅π±
Research Site, Wroclaw, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath